17.1
La toxicité médicamenteuse quantifie les dommages qu’un composé cause à un organisme, lesquels varient selon la dose et peuvent affecter des systèmes…
La toxicité des médicaments, souvent résultant d’une surdose, fait référence aux effets nocifs qu’une substance chimique peut avoir sur un organisme. Ces effets peuvent cibler des organes spécifiques, comme le foie, ou impacter le SNC.
Par exemple, une overdose d’analgésiques en vente libre peut provoquer des réactions indésirables, telles que des lésions hépatiques, des saignements d’estomac et des maladies rénales.
En revanche, une réaction indésirable au médicament, ou ADR, est une réponse nocive et non intentionnelle à un médicament lorsqu’il est utilisé dans sa période thérapeutique.
Ils peuvent être aigus, commençant en moins d’une heure ; sous-aigu, survenant en moins de 24 heures ; ou des réactions latentes, apparaissant des semaines à des mois après l’exposition.
Par exemple, les médicaments antihypertenseurs peuvent provoquer une hypotension, entraînant des vertiges ou des vertiges.
Les ADR peuvent être classées en six types, classés de A à F.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between drug toxicity and an adverse drug reaction?
Drug toxicity refers to harmful effects from a chemical substance, often resulting from overdose and potentially targeting specific organs like the liver or CNS. An adverse drug reaction (ADR) is a harmful, unintended response to a drug used within its therapeutic window. While toxicity typically involves exceeding safe doses, ADRs occur at therapeutic levels and represent unexpected responses to medications.
Q2: How are adverse drug reactions classified by onset time?
ADRs are classified by onset timing: acute reactions start within one hour, subacute reactions occur within 24 hours, and latent reactions appear weeks to months after exposure. For example, antihypertensive drugs may cause acute hypotension leading to dizziness. This classification helps clinicians recognize and manage reactions based on when symptoms emerge after drug administration.
Q3: What are Type A and Type B adverse drug reactions?
Type A ADRs are dose-related and predictable, resulting from the drug's pharmacological action, such as hypoglycemia from diabetes medication. Type B ADRs are unpredictable and not dose-dependent, often severe, affecting organs like the liver or skin through idiosyncratic or allergy-like reactions influenced by genetic and environmental factors.
Q4: What factors determine how toxic a substance is to an organism?
Substance toxicity depends on multiple factors including dose, exposure duration, chemical structure, and individual factors. Environmental toxins and mycotoxins pose significant risks through various mechanisms. Some substances like heroin and GHB are particularly lethal because their effective doses are close to toxic doses, leaving little margin for safety.
Q5: What are examples of common acute poisoning cases?
Common acute poisoning cases include ethanol intoxication and overdose of pain or fever medications like over-the-counter painkillers, which can cause liver damage, stomach bleeding, and kidney disease. Venomous insect or spider bites can also cause acute poisoning with effects ranging from mild symptoms to severe outcomes such as brain damage or death.
Q6: What do Type C, D, E, and F adverse drug reactions represent?
Type C ADRs are dose- and time-dependent effects. Type D reactions are delayed responses like carcinogenesis. Type E reactions involve withdrawal symptoms when medication is discontinued. Type F reactions represent unexpected therapy failure. These classifications extend beyond Type A and B to capture the full spectrum of adverse drug response patterns.
Q7: How does severity range in adverse drug reactions?
ADR severity ranges from mild to life-threatening, with severe cases requiring significant medical intervention or causing permanent damage. Reactions can be acute, subacute, or chronic based on onset timing. Understanding severity helps clinicians prioritize treatment and predict whether a reaction requires hospitalization, supportive care, or long-term management.